NASDAQ: PHXM - PHAXIAM Therapeutics S.A.

半年間の収益性: 0%
セクタ: Healthcare

プロモーションスケジュール PHAXIAM Therapeutics S.A.

詳細なスケジュール 簡易グラフ
Financial Markets by TradingView

会社について

PHAXIAM Therapeutics S.A., a biopharmaceutical company, focuses on developing treatments for resistant bacterial infections in France and the United States. It develops eryaspase, which is in Phase 3 clinical development for the treatment of second-line pancreatic cancer, and in Phase 2 stage for the treatment of triple-negative breast cancer and second-line acute lymphoblastic leukemia patients.

さらに詳しく
The company also engages in developing a portfolio of phages targeting resistant and dangerous bacteria, which together account for more than two-thirds of resistant hospital-acquired infections, including staphylococcus aureus, escherichia coli, and pseudomonas aeruginosa. The company was formerly known as ERYTECH Pharma S.A. and changed its name to PHAXIAM Therapeutics S.A. in June 2023. PHAXIAM Therapeutics S.A. was incorporated in 2004 and is headquartered in Lyon, France.
比較リストに追加
ウォッチリストに追加
ポートフォリオに追加
価格通知を追加

IPO date 2023-06-29
ISIN US29604W1080
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета eur
Сайт https://www.phaxiam.com
Цена ао 3.1
1日あたりの価格変動: 0% (3.1)
週ごとの価格変動: 0% (3.1)
月ごとの料金変更: 0% (3.1)
3ヶ月間の価格変動: 0% (3.1)
半年間の価格変動: 0% (3.1)
年間の価格変動: -30.18% (4.44)
3年間の価格推移: +40.91% (2.2)
5年間の価格推移: -40.38% (5.2)
10年間の価格推移: 0% (3.1)
年初からの価格変動: 0% (3.1)
すべてのパラメータ

過小評価

名前 意味 学年
P/S 0 0
P/BV 0 0
P/E 0 0
EV/EBITDA 0 0
合計: 2.5

効率

名前 意味 学年
ROA, % 0 0
ROE, % 0 0
合計: 0

配当金

名前 意味 学年
Div yield, % 0 0
DSI 0 0
合計: 0

義務

名前 意味 学年
Debt/EBITDA 0 10
合計: 10

成長の衝動

名前 意味 学年
収益性 Revenue, % 972.92 10
収益性 Ebitda, % -39.35 0
収益性 EPS, % -99.68 0
合計: 2
さらに詳しく



スーパーバイザー 役職 支払い 生年
Mr. Eric Soyer Ph.D. Deputy CEO, Deputy GM, CFO & COO 418.14k 1966 (59 年)
Dr. Jérôme Bailly Pharm.D. Deputy CEO, Deputy GM, Chief Quality Officer & Qualified Person 272.99k 1979 (46 年)
Mr. Thibaut du Fayet Chief Executive Officer N/A 1968 (57 年)
Ms. Céline Breda Chief Technology Officer N/A 1971 (54 年)
Ms. Cindy Fevre Chief Scientific Officer N/A
Naomi Eichenbaum Director Investor Relations N/A
Ms. Anne-Cécile Fumey Vice President of Human Resources N/A 1976 (49 年)
Ms. Karine Charton Ph.D. Chief Business Officer N/A
Ms. Frederique Vieville Chief Regulatory Officer N/A
Dr. Pascal Birman M.D. Chief Medical Officer

住所: France, Lyon, 60 Avenue Rockefeller - Googleマップで開く, Yandexマップを開く
Webサイト: https://www.phaxiam.com